Conditions: Major Depression Cancer Diabetes Cardiovascular Diseases
Keywords: Omega 3 fatty acid Fish oil Depression cancer diabetes high blood pressure cardiovascular
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 6
Healthy volunteers: no

Brief summary:
To assess the efficacy of Omega 3 Fatty acid (Omega 3 FA) augmentation of desvenlafaxine (DVS) compared to placebo augmentation of DVS when used to treat depression and anxiety symptoms in patients with select medical conditions (cancer, cardiovascular diseases and diabetes).

Detailed description:

Arms:
arm 1: Desvenlafaxine 50mg/day \& Omega 3 FA supplement (range 2.4 gm/day - 4.8 gm day) over a 12 week period arm 2: Desvenlafaxine 50mg/day \& Placebo (for Omega 3 FA supplement) over a 12 week period

Interventions: intervention 1: Desvenlafaxine intervention 2: Omega 3 Fatty acids intervention 3: Placebo (for Omega 3 fatty acid supplement)
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None

Protocol document: